Elite Traders Group Offers Insights on Biotech Industry Comparing It to the Next Computer Age
January 14 2013 - 7:37PM
Marketwired
Insights on the Following Companies:
International Stem Cell Corporation, Kraig
Biocraft Laboratories, Inc. ScripsAmerica, Inc., Celsion Corp.
Biotech researchers across the world are experiencing a
renaissance in their industry. Like the massive growth experienced
by technology companies of the 90s, the biotech industry is prepped
and ready to realize the same growth. Technology has provided new
ways to research treatments, therapies and distribute new drugs.
Many small biotech companies have taken advantage of this new
technology and are the source of these new drugs. With many patents
expiring in 2012, the large corporations are beginning to acquire
these smaller companies in an effort to attain new patents.
With new discoveries every day in the biotech industry the shelf
life of a new drug is becoming shorter. According to information
gathered by Bloomberg, 676 biotech takeovers occurred in rising
numbers over the last 3 years. Expect this trend to continue over
the next 3 years, as more patents will expire and new drugs will be
discovered at an increasingly higher rate.
Researchers have just started to scratch the surface in this
young and exciting field. 2012 revealed many advances in the
Anti-obesity, Myelofibrosis, cancer, HCV, RA, MS, psoriasis, HCC,
and dyslipidemia fields. 2013 promises to discover new treatments
for viruses, targeted cancer treatments, Alzheimer's, antivirals
and orphan diseases. In addition, many oral therapies are being
researched in the areas of RA, Psoriasis, and MS. Stem cell
research will also be represented well in 2013.
Investors continue to be unafraid of the lengthy and difficult
process to achieve FDA approval. In fact, many have plans to
increase the M&A budgets. Many small biotech companies are also
seeing the oncoming wave of advancements in this field and have
decided to take on the challenge of doing their own marketing. The
rewards well outweigh the risks for these small biotech
companies.
The biotech industry has many up and coming companies that are
worth taking a closer look.
International Stem Cell Corporation
(OTCQB: ISCO) is focused on the therapeutic applications of human
parthenogenetic stem cells and the development and
commercialization of cell-based research and cosmetic products.
ISCO's core technology, parthenogenesis, results in the creation of
pluripotent human stem cells from unfertilized oocytes (eggs).
http://www.firstpennypicks.com/get-your-free-research-report/
Kraig Biocraft Laboratories, Inc. (OTCQB:
KBLB) is a biotechnology company focused on the development of high
performance polymers. Kraig works in cooperation with leading
universities in the fields of genetics and genetic engineering to
develop new recombinant fibers and materials which the company
believes will have broad commercial applications.
http://www.firstpennypicks.com/get-your-free-research-report/
ScripsAmerica, Inc. (OTCQB: SCRC) delivers
pharmaceutical products to a wide range of end users across the
health care industry, including physicians' offices, retail
pharmacies, long-term care sites, hospitals, and Government and
home care agencies through the largest pharmaceutical distributor
in North America, McKesson Corporation. Current therapeutic
categories serviced by the Company include pain, arthritis,
prenatal, urinary, and hormonal replacement drugs. Other customers
of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals,
MedVet and the United States Veterans Administration.
http://www.firstpennypicks.com/get-your-free-research-report/
Celsion Corp. (NASDAQ: CLSN) is a leading
oncology company dedicated to the development and commercialization
of innovative cancer drugs including tumor-targeting treatments
using focused heat energy in combination with heat-activated
liposomal drug technology. Celsion has research, license, or
commercialization agreements with leading institutions including
the National Institutes of Health, Duke University Medical Center,
University of Hong Kong, the University of Pisa, the UCLA
Department of Medicine, the Kyungpook National University Hospital
and the Beijing Cancer Hospital.
http://www.firstpennypicks.com/get-your-free-research-report/
To Receive More Reports like this one Subscribe
free at http://www.FirstPennyPicks.com
VIP Group
Increase Your Day Trading Profits by joining
our VIP Pre-promotion/Early Alert Membership For only $29.95/month
or $295/year:
http://www.firstpennypicks.com/vip-membership/
http://www.Firstpennypicks.com was developed as a beacon of hope
in the micro-cap stock newsletter industry. We always hand-pick our
alerts as opposed to biased advertising. This is
why we are the fastest growing community of micro-cap traders on
the web.
Please note that all media from Elite Traders Group LLC and
FirstPennyPicks.com is investment opinion only.
Elite Traders Group employees are not registered as an
Investment Adviser in any jurisdiction whatsoever. This
advertisement is for informational purposes only and is not
intended to be a recommendation to buy or sell securities in any of
the profiled companies listed here.
FULL DISCLAIMER http://www.firstpennypicks.com/disclaimer/
Contact: Elite Traders Group LLC Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024